Contribution of the Community Pharmacies on the Spanish Health System Pharmacy in the period 1996 to 2010



Description


Antares Consulting has developed this study aiming to demonstrate the loss of profitability in the sector of access to medication as well as to quantitatively demonstrate the efforts of this sector in recent years.


The study focuses on the Community Pharmacy during the period of 1996 to 2010. 

 

Contents:

 

CONTEXT

 

  • Public spending on drugs in Spain
  • Change in public expenditure on drugs.
  • Evolution of the average cost of drugs per capita.
  • Public spending on medications in respect to health spending in Spain.
  • Health and medication spending by GDP per capita.
  • Growth in pharmaceutical (public) spending vs. Growth in nominal and real GDP 

MARGIN EVOLUTION IN THE SECTOR OF ACCESS TO MEDICINE

 

  • Description and evolution of the factors that have affected the scope of access to the drug industry in recent years (1996-2006)


 a) Margins of the drug
 b) Average price per prescription 
 c) Reference price
 d) Discounts
 e) Other factors

 

  • Chronological analysis of the measures in savings on drug spending from 1996 - 2009.
  • Impact on the margin of the Community Pharmacy 

CONCLUSIONS

 

ALTERNATIVES TO THE REAL CAUSES OF PHARMACEUTICAL SPENDING



Authors


Antares Consulting



An Open-Innovation Test Bed for Medical Devices: Kick-off for new EU Research Project TBMED

13 European partners aim to accelerate patient access to innovative solutions

News  February 26, 2019
Copyright © 2010 Antares Consulting S.A. All rights reserved   |   Terms of use   |   Privacy Police